Differential phosphorylation of IRS-1 and IRS-2 by insulin and IGF-I receptors

References

• Amoui M, Craddock B P, Miller W T. Differential phosphorylation of IRS-1 by insulin and insulin-like growth factor I receptors in Chinese hamster ovary cells. J Endocrinol 2001; 171: 153–162
   PubMed Web of Science ®Google Scholar
• Bailyes E M, Nave B T, Soos M A, Orr S R, Hayward A C, Siddle K. Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting. Biochem J 1997; 327: 209–215
   PubMed Web of Science ®Google Scholar
• Baudry A, Lamothe B, Bucchini D, Jami J, Montarras D, Pinset C, Joshi R L. IGF-1 receptor as an alternative receptor for metabolic signaling in insulin receptor-deficient muscle cells. FEBS Lett 2001; 488: 174–178
   PubMed Web of Science ®Google Scholar
• Beguinot F, Kahn C R, Moses A C, Smith R J. Distinct biologically active receptors for insulin, insulin-like growth factor I, and insulin-like growth factor II in cultured skeletal muscle cells. J Biol Chem 1985; 260: 15892–15898
   PubMed Web of Science ®Google Scholar
• Bornfeldt K E, Gidlof R A, Wasteson A, Lake M, Skottner A, Arnqvist H J. Binding and biological effects of insulin, insulin analogs and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities. Diabetologia 1991; 34: 307–313
   PubMed Web of Science ®Google Scholar
• Brunetti A, Maddux B A, Wong K Y, Goldfine I D. Muscle cell differentiation is associated with increased insulin receptor biosynthesis and messenger RNA levels. J Clin Invest 1989; 83: 192–198
   PubMed Web of Science ®Google Scholar
• Cheng Z Q, Adi S, Wu N Y, Hsiao D, Woo E J, Filvaroff E H, Gustafson T A, Rosenthal S M. Functional inactivation of the IGF-I receptor delays differentiation of skeletal muscle cells. J Endocrinol 2000; 167: 175–182
   PubMed Web of Science ®Google Scholar
• Crown A L, He X L, Holly J M, Lightman S L, Stewart C E. Characterisation of the IGF system in a primary adult human skeletal muscle cell model, and comparison of the effects of insulin and IGF-I on protein metabolism. J Endocrinol 2000; 167: 403–415
   PubMed Web of Science ®Google Scholar
• De Meyts P, Wallach B, Christoffersen C T, Urso B, Gronskov K, Latus L J, Yakushiji F, Ilondo M M, Shymko R M. The insulin-like growth factor-I receptor. Structure, ligand-binding mechanism and signal transduction. Horm Res 1994; 42: 152–169
   PubMed Web of Science ®Google Scholar
• De Meyts P, Christoffersen C T, Urso B, Wallach B, Gronskov K, Yakushiji F, Shymko R M. Role of the time factor in signaling specificity: application to mitogenic and metabolic signaling by the insulin and insulin-like growth factor-I receptor tyrosine kinases. Metabolism 1995; 44(Suppl 4)2–11
   PubMedGoogle Scholar
• Dietze D, Koenen M, Rohrig K, Horikoshi H, Hauner H, Eckel J. Impairment of insulin signaling in human skeletal muscle cells by co-culture with human adipocytes. Diabetes 2002; 51: 2369–2376
   PubMed Web of Science ®Google Scholar
• Drejer K, Kruse V, Larsen U D, Hougaard P, Bjorn S, Gammeltoft S. Receptor binding and tyrosine kinase activation by insulin analogues with extreme affinities studied in human hepatoma HepG2 cells. Diabetes 1991; 40: 1488–1495
   PubMed Web of Science ®Google Scholar
• Fasshauer M, Klein J, Ueki K, Kriauciunas K M, Benito M, White M F, Kahn C R. Essential role of insulin receptor substrate-2 in insulin stimulation of Glut4 translocation and glucose uptake in brown adipocytes. J Biol Chem 2000; 275: 25494–25501
   PubMed Web of Science ®Google Scholar
• Fasshauer M, Klein J, Kriauciunas K M, Ueki K, Benito M, Kahn C R. Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes. Mol Cell Biol 2001; 21: 319–329
   PubMed Web of Science ®Google Scholar
• Federici M, Porzio O, Zucaro L, Fusco A, Borboni P, Lauro D, Sesti G. Distribution of insulin/insulin-like growth factor-I hybrid receptors in human tissues. Mol Cell Endocrinol 1997; 129: 121–126
   PubMed Web of Science ®Google Scholar
• Fernandez A M, Dupont J, Farrar R P, Lee S, Stannard B, Le Roith D. Muscle-specific inactivation of the IGF-I receptor induces compensatory hyperplasia in skeletal muscle. J Clin Invest 2002; 109: 347–355
   PubMed Web of Science ®Google Scholar
• He W, Craparo A, Zhu Y, O'Neill T J, Wang L M, Pierce J H, Gustafson T A. Interaction of insulin receptor substrate-2 (IRS-2) with the insulin and insulin-like growth factor I receptors. Evidence for two distinct phosphotyrosine-dependent interaction domains within IRS-2. J Biol Chem 1996; 271: 11641–11645
   PubMed Web of Science ®Google Scholar
• Jetton T L, Liu Y Q, Trotman W E, Nevin P W, Sun X J, Leahy J L. Enhanced expression of insulin receptor substrate-2 and activation of protein kinase B/Akt in regenerating pancreatic duct epithelium of 60%-partial pancreatectomy rats. Diabetologia 2001; 44: 2056–2065
   PubMed Web of Science ®Google Scholar
• Kasuya J, Paz I B, Maddux B A, Goldfine I D, Hefta S A, Fujita-Yamaguchi Y. Characterization of human placental insulin-like growth factor-I/insulin hybrid receptors by protein microsequencing and purification. Biochemistry 1993; 32: 13531–13536
   PubMed Web of Science ®Google Scholar
• Kurtzhals P, Schaffer L, Sorensen A, Kristensen C, Jonassen I, Schmid C, Trub T. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 2000; 49: 999–1005
   PubMed Web of Science ®Google Scholar
• Lamothe B, Baudry A, Christoffersen C T, De Meyts P, Jami J, Bucchini D, Joshi R L. Insulin receptor-deficient cells as a new tool for dissecting complex interplay in insulin and insulin-like growth factors. FEBS Lett 1998; 426: 381–385
   PubMed Web of Science ®Google Scholar
• Miele C, Caruso M, Calleja V, Auricchio R, Oriente F, Formisano P, Condorelli G, Cafieri A, Sawka-Verhelle D, Van Obberghen E, Beguinot F. Differential role of insulin receptor substrate (IRS)-1 and IRS-2 in L6 skeletal muscle cells expressing the Arg1152 → Gln insulin receptor. J Biol Chem 1999; 274: 3094–3102
   PubMed Web of Science ®Google Scholar
• Milazzo G, Sciacca L, Papa V, Goldfine I D, Vigneri R. ASPB10 insulin induction of increased mitogenic responses and phenotypic changes in human breast epithelial cells: evidence for enhanced interactions with the insulin-like growth factor-I receptor. Mol Carcinog 1997; 18: 19–25
   PubMed Web of Science ®Google Scholar
• Nakae J, Kido Y, Accili D. Distinct and overlapping functions of insulin and IGF-I receptors. Endocr Rev 2001; 22: 818–835
   PubMed Web of Science ®Google Scholar
• Pandini G, Frasca F, Mineo R, Sciacca L, Vigneti R, Belfiore A. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. J Biol Chem 2002; 277: 39684–39695
   PubMed Web of Science ®Google Scholar
• Pederson T, Rondinone C M. Regulation of proteins involved in insulin signaling pathways in differentiating human adipocytes. Biochem Biophys Res Commun 2000; 276: 162–168
   PubMed Web of Science ®Google Scholar
• Rakatzi I, Ramrath S, Ledwig D, Dransfeld O, Bartels T, Seipke G, Eckel J. A novel insulin analog with unique properties: LysB3,GluB29 insulin induces prominent activation of IRS-2 but marginal phosphorylation of IRS-1. Diabetes 2003; 52: 2227–2238
   PubMed Web of Science ®Google Scholar
• Rosenthal S M, Brunetti A, Brown E J, Mamula P W, Goldfine I D. Regulation of insulin-like growth factor (IGF) I receptor expression during muscle cell differentiation. Potential autocrine role of IGF-II. J Clin Invest 1991; 87: 1212–1219
   PubMed Web of Science ®Google Scholar
• Rother K I, Imai Y, Caruso M, Beguinot F, Formisano P, Accili D. Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes. J Biol Chem 1998; 273: 17491–17497
   PubMed Web of Science ®Google Scholar
• Sawka-Verhelle D, Baron V, Mothe I, Filloux C, White M F, Van Obberghen E. Tyr624 and Tyr628 in insulin receptor substrate-2 mediate its association with the insulin receptor. J Biol Chem 1997; 272: 16414–16420
   PubMed Web of Science ®Google Scholar
• Schacher D H, VanHoy R W, Liu Q, Arkins S, Dantzer R, Freund G G, Kelley K W. Developmental expression of insulin receptor substrate-2 during dimethylsulfoxide-induced differentiation of human HL-60 cells. J Immunol 2000; 164: 113–120
   PubMed Web of Science ®Google Scholar
• Shimizu M, Webster C, Morgan D O, Blau H M, Roth R A. Insulin and insulinlike growth factor receptors and responses in cultured human muscle cells. Am J Physiol 1986; 251: E611–E615
   PubMed Web of Science ®Google Scholar
• Shymko R M, Dumont E, De Meyts P, Dumont J E. Timing-dependence of insulin-receptor mitogenic versus metabolic signalling: a plausible model based on coincidence of hormone and effector binding. Biochem J 1999; 339: 675–683
   PubMed Web of Science ®Google Scholar
• Siddle K, Urso B, Niesler C A, Cope D L, Molina L, Surinya K H, Soos M A. Specificity in ligand binding and intracellular signalling by insulin and insulin-like growth factor receptors. Biochem Soc Trans 2001; 29: 513–525
   PubMed Web of Science ®Google Scholar
• Slieker L J, Brooke G S, DiMarchi R D, Flora D B, Green L K, Hoffmann J A, Long H B, Fan L, Shields J E, Sundell K L, Surface P L, Chance R E. Modifications in the B10 and B26-30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptor. Diabetologia 1997; 40(Suppl 2)54–61
   PubMedGoogle Scholar
• Soos M A, Siddle K. Immunological relationships between receptors for insulin and insulin-like growth factor I. Evidence for structural heterogeneity of insulin-like growth factor I receptors involving hybrids with insulin receptors. Biochem J 1989; 263: 553–563
   PubMed Web of Science ®Google Scholar
• Soos M A, Siddle K, Baron M D, Heward J M, Luzio J P, Bellatin J, Lennox E S. Monoclonal antibodies reacting with multiple epitopes on the human insulin receptor. Biochem J 1986; 235: 199–208
   Google Scholar
• Soos M A, Field C E, Lammers R, Ullrich A, Zhang B, Roth R A, Andersen A S, Kjeldsen T, Siddle K. A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. Epitope mapping, effects on ligand binding, and biological activity. J Biol Chem 1992; 267: 12955–12963
   PubMed Web of Science ®Google Scholar
• Soos M A, Field C E, Siddle K. Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity. Biochem J 1993; 290: 419–426
   PubMed Web of Science ®Google Scholar
• Stewart C E, Rotwein P. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev 1996; 76: 1005–1026
   PubMed Web of Science ®Google Scholar
• Virkamaki A, Ueki K, Kahn C R. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 1999; 103: 931–943
   PubMed Web of Science ®Google Scholar
• White M F. IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab 2002; 283: E413–E422
   PubMed Web of Science ®Google Scholar
• Yarden Y, Ullrich A. Growth factor receptor tyrosine kinases. Annu Rev Biochem 1988; 57: 443–478
   PubMed Web of Science ®Google Scholar